244 related articles for article (PubMed ID: 28561694)
41. Mantle Cell Lymphoma Under the Scope of Personalized Medicine: Perspective and Directions.
Gallucci Figorelle L; Galvão PT; de Lima FMR; Marimon P; Pentagna N; Milito C; Schaffel R; Carneiro K
Clin Lymphoma Myeloma Leuk; 2024 Jul; 24(7):433-445. PubMed ID: 38641485
[TBL] [Abstract][Full Text] [Related]
42. Biology and therapy of mantle cell lymphoma.
Williams ME; Densmore JJ
Curr Opin Oncol; 2005 Sep; 17(5):425-31. PubMed ID: 16093790
[TBL] [Abstract][Full Text] [Related]
43. What lies beneath: Cutaneous involvement of mantle cell lymphoma underlying an insect-bite-like reaction.
Shah RA; Powell PR; Parekh PK
J Cutan Pathol; 2021 Apr; 48(4):563-566. PubMed ID: 32776338
[TBL] [Abstract][Full Text] [Related]
44. Hematopoietic cell transplantation for mantle cell lymphoma.
Yanada M; Yamamoto K
Int J Hematol; 2022 Mar; 115(3):301-309. PubMed ID: 35092557
[TBL] [Abstract][Full Text] [Related]
45. Current overview and treatment of mantle cell lymphoma.
Schieber M; Gordon LI; Karmali R
F1000Res; 2018; 7():. PubMed ID: 30109020
[TBL] [Abstract][Full Text] [Related]
46. Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
Le Gouill S; Thieblemont C; Oberic L; Moreau A; Bouabdallah K; Dartigeas C; Damaj G; Gastinne T; Ribrag V; Feugier P; Casasnovas O; Zerazhi H; Haioun C; Maisonneuve H; Houot R; Jardin F; Van Den Neste E; Tournilhac O; Le Dû K; Morschhauser F; Cartron G; Fornecker LM; Canioni D; Callanan M; Béné MC; Salles G; Tilly H; Lamy T; Gressin R; Hermine O;
N Engl J Med; 2017 Sep; 377(13):1250-1260. PubMed ID: 28953447
[TBL] [Abstract][Full Text] [Related]
47. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
[TBL] [Abstract][Full Text] [Related]
48. [Cytarabine and hematopoietic cell transplantation for mantle cell lymphoma. Analysis of 20 patients].
Campbell J; Hurtado S; Kutz C; Soto K; Ernst D
Rev Med Chil; 2019; 147(1):9-17. PubMed ID: 30848759
[TBL] [Abstract][Full Text] [Related]
49. Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches.
Shah BD; Martin P; Sotomayor EM
Cancer Control; 2012 Jul; 19(3):227-35. PubMed ID: 22710898
[TBL] [Abstract][Full Text] [Related]
50. Transplantation for mantle cell lymphoma: is it the right thing to do?
Williams ME
Hematology Am Soc Hematol Educ Program; 2013; 2013():568-74. PubMed ID: 24319233
[TBL] [Abstract][Full Text] [Related]
51. Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma.
Assis-Mendonça GR; Fattori A; Rocha RM; Lourenço GJ; Delamain MT; Nonogaki S; de Lima VCC; Colleoni GWB; de Souza CA; Soares FA; Lima CSP; Vassallo J
BMC Cancer; 2021 Mar; 21(1):209. PubMed ID: 33648463
[TBL] [Abstract][Full Text] [Related]
52. Biology and management of mantle cell lymphoma.
Leonard JP; Schattner EJ; Coleman M
Curr Opin Oncol; 2001 Sep; 13(5):342-7. PubMed ID: 11555710
[TBL] [Abstract][Full Text] [Related]
53. Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network.
Dreyling M; Amador V; Callanan M; Jerkeman M; Le Gouill S; Pott C; Rule S; Zaja F;
Leuk Lymphoma; 2015 Apr; 56(4):866-76. PubMed ID: 25015778
[TBL] [Abstract][Full Text] [Related]
54. Molecular profiling and management of mantle cell lymphoma.
Ruan J
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):30-40. PubMed ID: 31808882
[TBL] [Abstract][Full Text] [Related]
55. [Mantle cell lymphoma: management in 2011].
Bonnet C; Caers J; De Prijck B; Hafraoui K; Beguin Y
Rev Med Suisse; 2011 Aug; 7(306):1644-9. PubMed ID: 21972731
[TBL] [Abstract][Full Text] [Related]
56. [Palpable mantel cell lymphoma in the breast].
Boullanger N; Renou P; Dugay J; Boyer J; de Yberlucea LR; Combe M; Coulon MA
Presse Med; 2001 Feb; 30(4):163-5. PubMed ID: 11229304
[TBL] [Abstract][Full Text] [Related]
57. What is the optimal initial management of the younger mantle cell lymphoma patient?
McCulloch R; Rule S
Best Pract Res Clin Haematol; 2018 Mar; 31(1):90-98. PubMed ID: 29452671
[TBL] [Abstract][Full Text] [Related]
58. [Mantle cell lymphoma: case report].
Méhes L; Telek B; Udvardy M; Schlammadinger A; és Rejto L
Orv Hetil; 2008 Aug; 149(31):1471-4. PubMed ID: 18632508
[TBL] [Abstract][Full Text] [Related]
59. Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group.
Yoon DH; Cao J; Chen TY; Izutsu K; Kim SJ; Kwong YL; Lin TY; Thye LS; Xu B; Yang DH; Kim WS
J Hematol Oncol; 2020 Mar; 13(1):21. PubMed ID: 32183871
[TBL] [Abstract][Full Text] [Related]
60. Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era?
Chaudhary L; Kharfan-Dabaja MA; Hari P; Hamadani M
Bone Marrow Transplant; 2013 Nov; 48(12):1489-96. PubMed ID: 23584438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
